Nova Patents
AT475660T

Anti-viral compounds

Abstract

Compounds effective in inhibiting replication of Hepatitis C virus (“HCV” or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates forthe syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

73 members in 18 offices

This recordMember, by publication datePriority claim8 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
75247305United States of AmericaP
2006049080United States of AmericaW
61383606United States of AmericaA

Members73

Family members, oldest first
DocumentOfficeKind
AU2006330924A1AustraliaA1
CA2633757A1CanadaA1
CA2633760A1CanadaA1
WO2007076034A2World Intellectual Property Organization (WIPO)A2
WO2007076035A2World Intellectual Property Organization (WIPO)A2
CA2633752A1CanadaA1
WO2007081517A2World Intellectual Property Organization (WIPO)A2
US2007197558A1United States of AmericaA1
WO2007081517A8World Intellectual Property Organization (WIPO)A8
US2007232627A1United States of AmericaA1
US2007232645A1United States of AmericaA1
WO2007076034A3World Intellectual Property Organization (WIPO)A3
WO2007076035A3World Intellectual Property Organization (WIPO)A3
TW200738707ATaiwan Province of ChinaA
TW200745107ATaiwan Province of ChinaA
WO2007081517A3World Intellectual Property Organization (WIPO)A3
TW200800991ATaiwan Province of ChinaA
TW200831513ATaiwan Province of ChinaA
KR20080080395ARepublic of KoreaA
EP1971611A1European Patent Office (EPO)A1
EP1979348A2European Patent Office (EPO)A2
EP1979349A2European Patent Office (EPO)A2
CA2672737A1CanadaA1
WO2008133753A2World Intellectual Property Organization (WIPO)A2
WO2008133753A3World Intellectual Property Organization (WIPO)A3
IL192306A0IsraelA0
CN101384591AChinaA
CN101384592AChinaA
HK1122291AHong Kong, ChinaA
HK1122291A1Hong Kong, ChinaA1
HK1122292AHong Kong, ChinaA
CN101443334AChinaA
JP2009521460AJapanA
JP2009521479AJapanA
JP2009521480AJapanA
EP2094276A2European Patent Office (EPO)A2
RU2008129782ARussian FederationA
RU2008129810ARussian FederationA
RU2008129807ARussian FederationA
BRPI0620440A2BrazilA2
US7763731B2United States of AmericaB2
EP1979349B1European Patent Office (EPO)B1
AT475660TThis recordAustriaT
ATE475660T1AustriaT1
DE602006015861D1GermanyD1
US2010256139A1United States of AmericaA1
ES2348557T3SpainT3
EP2094276A4European Patent Office (EPO)A4
US7910595B2United States of AmericaB2
US7915411B2United States of AmericaB2
US2011160233A1United States of AmericaA1
EP2345652A1European Patent Office (EPO)A1
NZ569817ANew ZealandA
ZA200805418BSouth AfricaB
EP1979348B1European Patent Office (EPO)B1
ZA200805304BSouth AfricaB
RU2441010C2Russian FederationC2
RU2441869C2Russian FederationC2
AT541844TAustriaT
ATE541844T1AustriaT1
AU2006330924B2AustraliaB2
ES2378473T3SpainT3
ZA201107667BSouth AfricaB
US8236950B2United States of AmericaB2
CN102702193AChinaA
CN102702194AChinaA
EP1971611B1European Patent Office (EPO)B1
RU2467007C2Russian FederationC2
US8338605B2United States of AmericaB2
ES2395386T3SpainT3
TWI392676BTaiwan Province of ChinaB
TWI392677BTaiwan Province of ChinaB
TWI399380BTaiwan Province of ChinaB